Citations (88)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Xiao Wang & Tianzuo Li. (2020) Development of a 15-gene signature for predicting prognosis in advanced colorectal cancer. Bioengineered 11:1, pages 165-174.
Read now
Read now
MA Haoyuan & LI Yanshu. (2020) Structure, regulatory factors and cancer-related physiological effects of ADAM9. Cell Adhesion & Migration 14:1, pages 165-181.
Read now
Read now
Francis P Young, David Ende & Richard J Epstein. (2019) Beyond BCG: The Approaching Era of Personalised Bladder-Sparing Therapies for Non-Muscle-Invasive Urothelial Cancers. Future Oncology 15:4, pages 409-420.
Read now
Read now
Mariana Brait, Enrico Munari, Cynthia LeBron, Maartje G. Noordhuis, Shahnaz Begum, Christina Michailidi, Nilda Gonzalez-Roibon, Leonel Maldonado, Tanusree Sen, Rafael Guerrero-Preston, Leslie Cope, Paola Parrella, Vito Michele Fazio, Patrick K. Ha, George J. Netto, David Sidransky & Mohammad O. Hoque. (2013) Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma. Cell Cycle 12:7, pages 1058-1070.
Read now
Read now
Ana Isabel Oliveira, Carmen Jerónimo & Rui Henrique. (2012) Moving forward in bladder cancer detection and diagnosis: the role of epigenetic biomarkers. Expert Review of Molecular Diagnostics 12:8, pages 871-878.
Read now
Read now
Antonia Vlahou. (2011) Back to the future in bladder cancer research. Expert Review of Proteomics 8:3, pages 295-297.
Read now
Read now
Peter H Roos & Norbert Jakubowski. (2010) Methods for The Discovery of Low-Abundance Biomarkers for Urinary Bladder Cancer in Biological Fluids. Bioanalysis 2:2, pages 295-309.
Read now
Read now
Articles from other publishers (81)
Sainab Totonji, Anna Ramos-Triguero, Dominica Willmann, Manuela Sum, Sylvia Urban, Helena Bauer, Astrid Rieder, Sheng Wang, Holger Greschik, Eric Metzger & Roland Schüle. (2024) Lysine Methyltransferase 9 (KMT9) Is an Actionable Target in Muscle-Invasive Bladder Cancer. Cancers 16:8, pages 1532.
Crossref
Crossref
Yuji Nitta, Tomomi Fujii, Tomoko Uchiyama, Aya Sugimoto, Takeshi Nishikawa, Maiko Takeda, Makito Miyake, Keiji Shimada & Kiyohide Fujimoto. (2023) Overexpression of MicroRNA-138 Affects the Proliferation and Invasion of Urothelial Carcinoma Cells by Suppressing SOX9 Expression. Biomedicines 11:11, pages 3064.
Crossref
Crossref
Selim TAŞ, Ali Erhan EREN, Mahmut Taha ÖLÇÜCÜ, Barış PAKSOY, Ekrem İSLAMOĞLU & Mehmet Salih BOĞA. (2023) Is There A Genetic Predisposition for Transitional Cell Carcinoma of the Bladder at a Young Age?Genç Yaşta Görülen Transizyonel Hücreli Mesane Karsinomunda Genetik Yatkınlık Var Mıdır?. Endouroloji Bulteni, pages 102-108.
Crossref
Crossref
Zhenmei Yao, Ning Xu, Guoguo Shang, Haixing Wang, Hui Tao, Yunzhi Wang, Zhaoyu Qin, Subei Tan, Jinwen Feng, Jiajun Zhu, Fahan Ma, Sha Tian, Qiao Zhang, Yuanyuan Qu, Jun Hou, Jianming Guo, Jianyuan Zhao, Yingyong Hou & Chen Ding. (2023) Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ. Nature Communications 14:1.
Crossref
Crossref
Mauro Nascimben, Lia Rimondini, Davide Corà & Manolo Venturin. (2022) Polygenic risk modeling of tumor stage and survival in bladder cancer. BioData Mining 15:1.
Crossref
Crossref
Jiufeng Tan, Yao Wang, Lihui Sun, Siqi Xu, Charles Li & Xuefei Jin. (2022) The Origin and Evolution of Bladder Cancer Stem Cells. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Fangming Wang, Xiying Dong, Feiya Yang & Nianzeng Xing. (2022) Comparative Analysis of Differentially Mutated Genes in Non-Muscle and Muscle-Invasive Bladder Cancer in the Chinese Population by Whole Exome Sequencing. Frontiers in Genetics 13.
Crossref
Crossref
Jianya Huan, Petros Grivas, Jasmine Birch & Donna E. Hansel. (2022) Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy. Cancers 14:6, pages 1555.
Crossref
Crossref
Yi Li, Lihui Sun, Xiangyang Guo, Na Mo, Jinku Zhang & Chong Li. (2021) Frontiers in Bladder Cancer Genomic Research. Frontiers in Oncology 11.
Crossref
Crossref
William L. Harryman, Kendra D. Marr, Daniel Hernandez-Cortes, Raymond B. Nagle, Joe G. N. Garcia & Anne E. Cress. (2021) Cohesive cancer invasion of the biophysical barrier of smooth muscle. Cancer and Metastasis Reviews 40:1, pages 205-219.
Crossref
Crossref
Kuan-Wei Shih, Wei-Chieh Chen, Ching-Hsin Chang, Ting-En Tai, Jeng-Cheng Wu, Andy C. Huang & Ming-Che Liu. (2021) Non-Muscular Invasive Bladder Cancer: Re-envisioning Therapeutic Journey from Traditional to Regenerative Interventions. Aging and disease 12:3, pages 868.
Crossref
Crossref
Francesco Alessandrino, Kristin Williams, Amin H. Nassar, Rahul Gujrathi, Stuart G. Silverman, Guru SonpavdeAtul B. Shinagare. (2020) Muscle-invasive Urothelial Cancer: Association of Mutational Status with Metastatic Pattern and Survival. Radiology 295:3, pages 572-580.
Crossref
Crossref
Sung Han Kim, Weon Seo Park, Boram Park, Jinsoo Chung, Jae Young Joung, Kang Hyun Lee & Ho Kyung Seo. (2020) Identification of Significant Prognostic Tissue Markers Associated with Survival in Upper Urinary Tract Urothelial Carcinoma Patients Treated with Radical Nephroureterectomy: A Retrospective Immunohistochemical Analysis Using Tissue Microarray. Cancer Research and Treatment 52:1, pages 128-138.
Crossref
Crossref
Thenappan Chandrasekar, Annette Erlich & Alexandre R. Zlotta. (2018) Molecular Characterization of Bladder Cancer. Current Urology Reports 19:12.
Crossref
Crossref
Jean V. Joseph, Ralph Brasacchio, Chunkit Fung, Jay Reeder, Kevin Bylund, Deepak Sahasrabudhe, Shu Yuan Yeh, Ahmed Ghazi, Patrick Fultz, Deborah Rubens, Guan Wu, Eric Singer, Edward Schwarz, Supriya Mohile, James Mohler, Dan Theodorescu, Yi Fen Lee, Paul Okunieff, David McConkey, Hani Rashid, Chawnshang Chang, Yves Fradet, Khurshid Guru, Janet Kukreja, Gerald Sufrin, Yair Lotan, Howard Bailey, Katia Noyes, Seymour Schwartz, Kathy Rideout, Gennady Bratslavsky, Steven C. Campbell, Ithaar Derweesh, Per-Anders Abrahamsson, Mark Soloway, Leonard Gomella, Dragan Golijanin, Robert Svatek, Thomas Frye, Seth Lerner, Ganesh Palapattu, George Wilding, Michael Droller & Donald Trump. (2018) A Festschrift in Honor of Edward M. Messing, MD, FACS. Bladder Cancer 4:s1, pages S1-S43.
Crossref
Crossref
François Audenet, Kyrollis Attalla & John P. Sfakianos. (2018) The evolution of bladder cancer genomics: What have we learned and how can we use it?. Urologic Oncology: Seminars and Original Investigations 36:7, pages 313-320.
Crossref
Crossref
Ju Hyun Shin, Jae Sung Lim & Byeong Hwa Jeon. 2018. Bladder Cancer. Bladder Cancer
33
41
.
Yi Li, Kaisu Lin, Zhao Yang, Ning Han, Xiaofang Quan, Xiangyang Guo & Chong Li. (2017) Bladder cancer stem cells: clonal origin and therapeutic perspectives. Oncotarget 8:39, pages 66668-66679.
Crossref
Crossref
Skender Saidi, Zivko Popov, Vesna Janevska & Sasho Panov. (2017) Overexpression of UHRF1 gene correlates with the major clinicopathological parameters in urinary bladder cancer. International braz j urol 43:2, pages 224-229.
Crossref
Crossref
Theodoros Tokas, Margaritis Avgeris, Christos Alamanis, Andreas Scorilas, Konstantinos G. Stravodimos & Constantinos A. Constantinides. (2016) Downregulated KLK13 expression in bladder cancer highlights tumor aggressiveness and unfavorable patients’ prognosis. Journal of Cancer Research and Clinical Oncology 143:3, pages 521-532.
Crossref
Crossref
Nikolaos Koletsas, Triantafyllia Koletsa, Spyros Choidas, Konstantinos Anagnostopoulos, Stavros Touloupidis, Thomas Zaramboukas, Georgia Raptou, Nikolaos Papadopoulos & Maria Lambropoulou. (2017) Immunohistochemical Investigation of HER/AKT/mTOR Pathway and Cellular Adhesion Molecules in Urothelial Carcinomas. Pathology Research International 2017, pages 1-7.
Crossref
Crossref
Nakho Chang, Hye Won Lee, Joung Eun Lim, Da Eun Jeong, Hye Jin Song, Sudong Kim, Do-Hyun Nam, Hyun Hwan Sung, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, Han-Yong Choi & Hwang Gyun Jeon. (2016) Establishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletion. Oncotarget 7:32, pages 51626-51639.
Crossref
Crossref
Da-Wei Tian, Hai-Long Hu, Yan Sun, Yang Tang, Ming-De Lei, Li-Wei Liu, Rui-Fa Han & Chang-Li Wu. (2016) Biological effects of eukaryotic recombinant plasmid pReceiver-M61-BAI-1 transfection on T24 cells and HUVECs. Molecular Medicine Reports 14:2, pages 1553-1559.
Crossref
Crossref
Qiuli Liu, Wenqiang Yuan, Dali Tong, Gaolei Liu, Weihua Lan, Dianzheng Zhang, Hualiang Xiao, Yao Zhang, Zaoming Huang, Junjie Yang, Jun Zhang & Jun Jiang. (2016) Metformin represses bladder cancer progression by inhibiting stem cell repopulation via COX2/PGE2/STAT3 axis. Oncotarget 7:19, pages 28235-28246.
Crossref
Crossref
Eva M. Wojcik & Stefan E. Pambuccian. 2016. The Paris System for Reporting Urinary Cytology. The Paris System for Reporting Urinary Cytology
1
4
.
Wei Tian & Jonathan I. Epstein. (2015) Invasive low-grade papillary urothelial carcinoma: an immunohistochemical study of 26 cases. Human Pathology 46:12, pages 1836-1841.
Crossref
Crossref
Harika Sabbineni, Abdulrahman Alwhaibi, Anna Goc, Fei Gao, Alanna Pruitt & Payaningal R. Somanath. (2015) Genetic deletion and pharmacological inhibition of Akt1 isoform attenuates bladder cancer cell proliferation, motility and invasion. European Journal of Pharmacology 764, pages 208-214.
Crossref
Crossref
Xiaoying Zhang, Conghui Han & Jantai He. (2015) Recent Advances in the Diagnosis and Management of Bladder Cancer. Cell Biochemistry and Biophysics 73:1, pages 11-15.
Crossref
Crossref
NING JIN, XUEFEI JIN, XINQUAN GU, WANLI NA, MUCHUN ZHANG & RUI ZHAO. (2015) Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis. Molecular Medicine Reports 12:2, pages 3170-3176.
Crossref
Crossref
Juan-Juan Sun, Yong Wu, Yong-Ming Lu, Hui-Zhi Zhang, Tao Wang, Xiao-Qun Yang, Meng-Hong Sun & Chao-Fu Wang. (2015) Immunohistochemistry and Fluorescence In Situ Hybridization Can Inform the Differential Diagnosis of Low-Grade Noninvasive Urothelial Carcinoma with an Inverted Growth Pattern and Inverted Urothelial Papilloma. PLOS ONE 10:7, pages e0133530.
Crossref
Crossref
XING AI, ZHUO-MIN JIA, JUAN WANG, GUI-PING DI, XU ZHANG, FENGLING SUN, TONG ZANG & XIUMEI LIAO. (2015) Bioinformatics analysis of the target gene of fibroblast growth factor receptor 3 in bladder cancer and associated molecular mechanisms. Oncology Letters 10:1, pages 543-549.
Crossref
Crossref
Zhuomin Jia, Xing Ai, Fengling Sun, Tong Zang, Yawei Guan & Feng Gao. (2015) Identification of New Hub Genes Associated with Bladder Carcinoma via Bioinformatics Analysis. Tumori Journal 101:1, pages 117-122.
Crossref
Crossref
Mauro Scaravilli, Paola Asero, Teuvo LJ Tammela, Tapio Visakorpi & Outi R Saramäki. (2014) Mapping of the chromosomal amplification 1p21-22 in bladder cancer. BMC Research Notes 7:1.
Crossref
Crossref
Theodoros Rampias, Paraskevi Vgenopoulou, Margaritis Avgeris, Alexander Polyzos, Konstantinos Stravodimos, Christos Valavanis, Andreas Scorilas & Apostolos Klinakis. (2014) A new tumor suppressor role for the Notch pathway in bladder cancer. Nature Medicine 20:10, pages 1199-1205.
Crossref
Crossref
Jason Van Batavia, Tammer Yamany, Andrei Molotkov, Hanbin Dan, Mahesh Mansukhani, Ekaterina Batourina, Kerry Schneider, Daniel Oyon, Mark Dunlop, Xue-Ru Wu, Carlos Cordon-Cardo & Cathy Mendelsohn. (2014) Bladder cancers arise from distinct urothelial sub-populations. Nature Cell Biology 16:10, pages 982-991.
Crossref
Crossref
Jiachen Zhou, Karl T. Kelsey, Edward Giovannucci & Dominique S. Michaud. (2014) Fluid intake and risk of bladder cancer in the Nurses' Health Studies. International Journal of Cancer 135:5, pages 1229-1237.
Crossref
Crossref
Glenda Nicioli da Silva, Elaine Aparecida de Camargo, André Luiz Ventura Sávio & Daisy Maria Fávero Salvadori. (2014) MRE11A and SKP2 genes are associated with the increased cytotoxicity induced by the synergistic effects of cisplatin and gemcitabine in bladder cancer cells. Molecular Biology Reports 41:7, pages 4613-4621.
Crossref
Crossref
A Y Jia, M Castillo-Martin, D M Bonal, M Sánchez-Carbayo, J M Silva & C Cordon-Cardo. (2014) MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9. British Journal of Cancer 110:12, pages 2945-2954.
Crossref
Crossref
RONG SHI, ZHEN ZHAO, HUI ZHOU, JUEYU ZHOU & WANLONG TAN. (2014) Lack of association between MTHFR Ala222Val and Glu429Ala polymorphisms and bladder cancer risk: A meta-analysis of case-control studies. Biomedical Reports 2:3, pages 396-403.
Crossref
Crossref
Francisco Ayala de la Peña, Keizo Kanasaki, Megumi Kanasaki, Sylvia Vong, Carlota Rovira & Raghu Kalluri. (2014) Specific Activation of K-RasG12D Allele in the Bladder Urothelium Results in Lung Alveolar and Vascular Defects. PLoS ONE 9:4, pages e95888.
Crossref
Crossref
Lujia Wang, Chenchen Feng, Guanxiong Ding, Qiang Ding, Zhongwen Zhou, Haowen Jiang & Zhong Wu. (2013) Ki67 and TP53 expressions predict recurrence of non-muscle-invasive bladder cancer. Tumor Biology 35:4, pages 2989-2995.
Crossref
Crossref
Yuding Wang, Michael R Lang, Christopher L Pin & Jonathan I Izawa. (2013) Comparison of the clonality of urothelial carcinoma developing in the upper urinary tract and those developing in the bladder. SpringerPlus 2:1.
Crossref
Crossref
Kien T. Mai, Trevor A. Flood, Phillip Williams, Zuzana Kos & Eric C. Belanger. (2013) Mixed low- and high-grade papillary urothelial carcinoma: histopathogenetic and clinical significance. Virchows Archiv 463:4, pages 575-581.
Crossref
Crossref
Hans Olsson, Per Hultman, Johan Rosell & Staffan Jahnson. (2012) Population-based study on prognostic factors for recurrence and progression in primary stage T1 bladder tumours. Scandinavian Journal of Urology 47:3, pages 188-195.
Crossref
Crossref
Slah Ouerhani, Karim Bougatef, Ismail Soltani, Amel Ben Ammar Elgaaied, Salem Abbes & Samia Menif. (2013) The prevalence and prognostic significance of KRAS mutation in bladder cancer, chronic myeloid leukemia and colorectal cancer. Molecular Biology Reports 40:6, pages 4109-4114.
Crossref
Crossref
Jing Xiao & Qiu Yiqing. (2013) Bioinformatics analysis of the gene expression profile in Bladder carcinoma. Genetics and Molecular Biology 36:2, pages 287-291.
Crossref
Crossref
Angela Y. Jia, Mireia Castillo-Martin, Josep Domingo-Domenech, Dennis M. Bonal, Marta Sánchez-Carbayo, Jose M. Silva & Carlos Cordon-Cardo. (2013) A Common MicroRNA Signature Consisting of miR-133a, miR-139-3p, and miR-142-3p Clusters Bladder Carcinoma in Situ with Normal Umbrella Cells. The American Journal of Pathology 182:4, pages 1171-1179.
Crossref
Crossref
R Saito, R Shirakawa, H Nishiyama, T Kobayashi, M Kawato, T Kanno, K Nishizawa, Y Matsui, T Ohbayashi, M Horiguchi, T Nakamura, T Ikeda, K Yamane, E Nakayama, E Nakamura, Y Toda, T Kimura, T Kita, O Ogawa & H Horiuchi. (2012) Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer. Oncogene 32:7, pages 894-902.
Crossref
Crossref
M.L. Villalobos León, R. Molina Villaverde, F. Navarro Expósito & M. Álvarez-Mon Soto. (2013) Cáncer de vejiga. Medicine - Programa de Formación Médica Continuada Acreditado 11:26, pages 1568-1577.
Crossref
Crossref
Camila B. Piantino, Sabrina T. Reis, Nayara I. Viana, Iran A. Silva, Denis R. Morais, Alberto A. Antunes, Nelson Dip, Miguel Srougi & Katia R. Leite. (2013) Prima-1 induces apoptosis in bladder cancer cell lines by activating p53. Clinics 68:3, pages 297-303.
Crossref
Crossref
Glenda Nicioli da Silva, Elaine Aparecida de Camargo & Daisy Maria Favero Salvadori. (2012) Toxicogenomic activity of gemcitabine in two TP53-mutated bladder cancer cell lines: special focus on cell cycle-related genes. Molecular Biology Reports 39:12, pages 10373-10382.
Crossref
Crossref
Jorunn Litlekalsoy, Jens G. Hostmark, Daniela Elena Costea, Martin Illemann & Ole Didrik Laerum. (2012) Time-dependent biological differences in molecular markers of high-grade urothelial cancer over 7 decades (ras proteins, pTEN, uPAR, PAI-1 and MMP-9). Virchows Archiv 461:5, pages 541-551.
Crossref
Crossref
Vinod H. Nargund, C.K. Tanabalan & M.N. Kabir. (2012) Management of Non–Muscle-Invasive (Superficial) Bladder Cancer. Seminars in Oncology 39:5, pages 559-572.
Crossref
Crossref
Petra Lenz, Ruth Pfeiffer, Dalsu Baris, Alan R. Schned, Mikiko Takikita, M. Cristina Poscablo, Molly Schwenn, Alison Johnson, Michael Jones, Masatoshi Kida, Kenneth P. Cantor, Nathaniel Rothman, Debra T. Silverman, Stephen M. Hewitt & Lee E. Moore. (2012) Cell-Cycle Control in Urothelial Carcinoma: Large-scale Tissue Array Analysis of Tumor Tissue from Maine and Vermont. Cancer Epidemiology, Biomarkers & Prevention 21:9, pages 1555-1564.
Crossref
Crossref
Jun Zhu, Xiangyang Pan, Zheng Zhang, Juan Gao, Luyu Zhang & Junxia Chen. (2012) Downregulation of integrin-linked kinase inhibits epithelial-to-mesenchymal transition and metastasis in bladder cancer cells. Cellular Signalling 24:6, pages 1323-1332.
Crossref
Crossref
Alan R. Schned, Petra Lenz, Lee E. Moore, Alison Johnson, Michael Jones, Masatoshi Kida, Debra T. Silverman, Molly Schwenn, Karl T. Kelsey, Angeline S. Andrew, Dalsu Baris & Margaret R. Karagas. (2012) Analysis of the Distribution and Temporal Trends of Grade and Stage in Urothelial Bladder Cancer in Northern New England from 1994 to 2004. ISRN Pathology 2012, pages 1-7.
Crossref
Crossref
Victoria T. Fabris, Catalina Lodillinsky, María Betina Pampena, Denise Belgorosky, Claudia Lanari & Ana María Eiján. (2012) Cytogenetic characterization of the murine bladder cancer model MB49 and the derived invasive line MB49-I. Cancer Genetics 205:4, pages 168-176.
Crossref
Crossref
Kathryn A. Bailey, Kathleen Wallace, Lisa Smeester, Sheau-Fung Thai, Douglas C. Wolf, Stephen W. Edwards & Rebecca C. Fry. (2012) Transcriptional Modulation of the ERK1/2 MAPK and NF-kB Pathways in Human Urothelial Cells After Trivalent Arsenical Exposure: Implications for Urinary Bladder Cancer. Journal of Cancer Research Updates 1:1.
Crossref
Crossref
David P. WoodJr.Jr.. 2012. Campbell-Walsh Urology. Campbell-Walsh Urology
2309
2334.e6
.
Juan Gao, Jun Zhu, Hong-Yan Li, Xiang-Yang Pan, Rong Jiang & Jun-Xia Chen. (2011) Small interfering RNA targeting integrin-linked kinase inhibited the growth and induced apoptosis in human bladder cancer cells. The International Journal of Biochemistry & Cell Biology 43:9, pages 1294-1304.
Crossref
Crossref
Glenda N. da Silva, Adriane F. Evangelista, Danielle A. Magalhães, Cláudia Macedo, Michelle C. Búfalo, Elza T. Sakamoto-Hojo, Geraldo A.S. Passos & Daisy M. F. Salvadori. (2010) Expression of genes related to apoptosis, cell cycle and signaling pathways are independent of TP53 status in urinary bladder cancer cells. Molecular Biology Reports 38:6, pages 4159-4170.
Crossref
Crossref
Imran Ahmad, Lukram Babloo Singh, Mona Foth, Carol-Ann Morris, Makoto Mark Taketo, Xue-Ru Wu, Hing Y. Leung, Owen J. Sansom & Tomoko Iwata. (2011)
K-Ras
and
β-catenin
mutations cooperate with
Fgfr3
mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder
. Disease Models & Mechanisms 4:4, pages 548-555.
Crossref
Crossref
Francisco Ayala de la Peña, Keizo Kanasaki, Megumi Kanasaki, Neelima Tangirala, Genta Maeda & Raghu Kalluri. (2011) Loss of p53 and Acquisition of Angiogenic MicroRNA Profile Are Insufficient to Facilitate Progression of Bladder Urothelial Carcinoma in Situ to Invasive Carcinoma. Journal of Biological Chemistry 286:23, pages 20778-20787.
Crossref
Crossref
Luis Eduardo Murgel de Castro Santos, Ana Carolina Trindade Guilhen, Renato Alves de Andrade, Larissa Garcia Sumi & Laura S. Ward. (2011) The role of TP53 PRO47SER and ARG72PRO single nucleotide polymorphisms in the susceptibility to bladder cancer. Urologic Oncology: Seminars and Original Investigations 29:3, pages 291-294.
Crossref
Crossref
I Ahmad, R Patel, Y Liu, L B Singh, M M Taketo, X-R Wu, H Y Leung & O J Sansom. (2011) Ras mutation cooperates with β-catenin activation to drive bladder tumourigenesis. Cell Death & Disease 2:3, pages e124-e124.
Crossref
Crossref
Orit Karni-Schmidt, Mireia Castillo-Martin, Tian HuaiShen, Nataliya Gladoun, Josep Domingo-Domenech, Marta Sanchez-Carbayo, Yingchun Li, Scott Lowe, Carol Prives & Carlos Cordon-Cardo. (2011) Distinct Expression Profiles of p63 Variants during Urothelial Development and Bladder Cancer Progression. The American Journal of Pathology 178:3, pages 1350-1360.
Crossref
Crossref
Junxia Chen, Xi Ou-Yang, Juan Gao, Jun Zhu, Xiaoyan He & Jiang Rong. (2010) Knockdown of ribonuclease inhibitor expression with siRNA in non-invasive bladder cancer cell line BIU-87 promotes growth and metastasis potentials. Molecular and Cellular Biochemistry 349:1-2, pages 83-95.
Crossref
Crossref
I Ahmad, J P Morton, L B Singh, S M Radulescu, R A Ridgway, S Patel, J Woodgett, D J Winton, M M Taketo, X-R Wu, H Y Leung & O J Sansom. (2010) β-Catenin activation synergizes with PTEN loss to cause bladder cancer formation. Oncogene 30:2, pages 178-189.
Crossref
Crossref
Ji-Min SeoKyung-Jin ChoEun-Young KimMan Ho ChoiBong Chul ChungJae-Hong Kim. (2011) Up-regulation of BLT2 is critical for the survival of bladder cancer cells. Experimental and Molecular Medicine 43:3, pages 129.
Crossref
Crossref
Takuji Tanaka, Katsuhito Miyazawa, Tetsuya Tsukamoto, Toshiya Kuno & Koji Suzuki. (2011) Pathobiology and Chemoprevention of Bladder Cancer. Journal of Oncology 2011, pages 1-23.
Crossref
Crossref
Luciana Schultz, Roula Albadine, Jessica Hicks, Sana Jadallah, Angelo M. DeMarzo, Ying‐Bei Chen, Matthew E. Neilsen, Mark L. Gonzalgo, David Sidransky, Mark Schoenberg & George J. Netto. (2010) Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy. Cancer 116:23, pages 5517-5526.
Crossref
Crossref
D. Fernandez & C. Durdux. (2010) Facteurs pronostiques biologiques des cancers de la vessie. Interactions avec la radiothérapieBiological prognostic factors in bladder cancer. Interactions with radiotherapy. Bio tribune magazine 36:1, pages 6-11.
Crossref
Crossref
Glenda Nicioli da Silva, João Paulo de Castro Marcondes, Elaine Aparecida de Camargo, Geraldo Aleixo da Silva Passos Júnior, Elza Tiemi Sakamoto-Hojo & Daisy Maria Fávero Salvadori. (2010)
Cell cycle arrest and apoptosis in
TP53
subtypes of bladder carcinoma cell lines treated with cisplatin and gemcitabine
. Experimental Biology and Medicine 235:7, pages 814-824.
Crossref
Crossref
Mireia Castillo-Martin, Josep Domingo-Domenech, Orit Karni-Schmidt, Tulio Matos & Carlos Cordon-Cardo. (2010) Molecular pathways of urothelial development and bladder tumorigenesis. Urologic Oncology: Seminars and Original Investigations 28:4, pages 401-408.
Crossref
Crossref
D. Fernandez & C. Durdux. (2010) Facteurs pronostiques biologiques des cancers de la vessie. Interactions avec la radiothérapieBiological prognostic factors in bladder cancer. Interactions with radiotherapy. Oncologie 12:7, pages 389-395.
Crossref
Crossref
Catherine Seager, Anna M. Puzio‐Kuter, Carlos Cordon‐Cardo, James McKiernan & Cory Abate‐Shen. (2010) Mouse Models of Human Bladder Cancer as a Tool for Drug Discovery. Current Protocols in Pharmacology 49:1.
Crossref
Crossref
CARLOS PALMEIRA, PAULA A. OLIVEIRA, CATARINA LAMEIRAS, TERESINA AMARO, VICTOR M. SILVA, CARLOS LOPES & LÚCIO SANTOS. (2010) Biological similarities between murine chemical-induced and natural human bladder carcinogenesis. Oncology Letters 1:2, pages 373-377.
Crossref
Crossref
Karin Rennstam, Anita Ringberg, Heather E. Cunliffe, Håkan Olsson, Göran Landberg & Ingrid Hedenfalk. (2009)
Genomic alterations in histopathologically normal breast tissue from
BRCA1
mutation carriers may be caused by BRCA1 haploinsufficiency
. Genes, Chromosomes and Cancer 49:1, pages 78-90.
Crossref
Crossref
Catherine M. Seager, Anna M. Puzio-Kuter, Trushar Patel, Shalini Jain, Carlos Cordon-Cardo, James Mc Kiernan & Cory Abate-Shen. (2009) Intravesical Delivery of Rapamycin Suppresses Tumorigenesis in a Mouse Model of Progressive Bladder Cancer. Cancer Prevention Research 2:12, pages 1008-1014.
Crossref
Crossref
Guru SonpavdeAymen A. Elfiky & Jonathan E. Rosenberg. (2009) Review: Novel agents for advanced bladder cancer. Therapeutic Advances in Medical Oncology 1:1, pages 37-50.
Crossref
Crossref
Anna M. Puzio-Kuter, Mireia Castillo-Martin, Carolyn W. Kinkade, Xi Wang, Tian Huai Shen, Tulio Matos, Michael M. Shen, Carlos Cordon-Cardo & Cory Abate-Shen. (2009)
Inactivation of
p53
and
Pten
promotes invasive bladder cancer
. Genes & Development 23:6, pages 675-680.
Crossref
Crossref